ID26305A - Benzamida tersubstitusi baru, pembuatan dan penggunaannya - Google Patents
Benzamida tersubstitusi baru, pembuatan dan penggunaannyaInfo
- Publication number
- ID26305A ID26305A IDW20002113A ID20002113A ID26305A ID 26305 A ID26305 A ID 26305A ID W20002113 A IDW20002113 A ID W20002113A ID 20002113 A ID20002113 A ID 20002113A ID 26305 A ID26305 A ID 26305A
- Authority
- ID
- Indonesia
- Prior art keywords
- production
- new substituted
- substituted benzamides
- benzamides
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19817461A DE19817461A1 (de) | 1998-04-20 | 1998-04-20 | Neue substituierte Benzamide, deren Herstellung und Anwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID26305A true ID26305A (id) | 2000-12-14 |
Family
ID=7865113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20002113A ID26305A (id) | 1998-04-20 | 1999-04-19 | Benzamida tersubstitusi baru, pembuatan dan penggunaannya |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6436925B1 (cs) |
| EP (1) | EP1073632A1 (cs) |
| JP (1) | JP2002512220A (cs) |
| KR (1) | KR20010042837A (cs) |
| CN (1) | CN1306509A (cs) |
| AU (1) | AU743245B2 (cs) |
| BG (1) | BG104856A (cs) |
| BR (1) | BR9909776A (cs) |
| CA (1) | CA2328430A1 (cs) |
| CZ (1) | CZ20003890A3 (cs) |
| DE (1) | DE19817461A1 (cs) |
| HR (1) | HRP20000777A2 (cs) |
| HU (1) | HUP0101616A3 (cs) |
| ID (1) | ID26305A (cs) |
| IL (1) | IL138676A0 (cs) |
| NO (1) | NO20005265D0 (cs) |
| PL (1) | PL343466A1 (cs) |
| SK (1) | SK14122000A3 (cs) |
| TR (1) | TR200003069T2 (cs) |
| WO (1) | WO1999054293A1 (cs) |
| ZA (1) | ZA200006758B (cs) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6720424B1 (en) * | 1999-07-01 | 2004-04-13 | Taisho Pharmaceutical Co., Ltd. | Aminobenzoic acid derivatives |
| CA2401749A1 (en) | 2000-03-23 | 2001-09-27 | Elan Pharmaceuticals, Inc. | Compounds and methods to treat alzheimer's disease |
| WO2002002518A2 (en) | 2000-06-30 | 2002-01-10 | Elan Pharmaceuticals, Inc. | Compounds to treat alzheimer's disease |
| US6846813B2 (en) * | 2000-06-30 | 2005-01-25 | Pharmacia & Upjohn Company | Compounds to treat alzheimer's disease |
| PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
| PE20020506A1 (es) * | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
| DE10114762A1 (de) * | 2001-03-26 | 2002-10-02 | Knoll Gmbh | Verwendung von Cysteinprotease-Inhibitoren |
| BR0210721A (pt) | 2001-06-27 | 2004-07-20 | Elan Pharm Inc | Composto, sal ou éster farmaceuticamente aceitável, método para fabricar um composto, e, método para tratar um paciente que tem, ou para evitar que o paciente adquira uma doença ou condição |
| JP2005504040A (ja) * | 2001-08-03 | 2005-02-10 | スミスクライン ビーチャム コーポレーション | カテプシンＫ阻害剤としてのα−ケトアミド誘導体 |
| GB0124941D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
| GB0124931D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
| GB0124932D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
| GB0124933D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
| GB0124934D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
| GB0124938D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
| GB0124936D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
| GB0124939D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
| WO2003062192A1 (en) | 2002-01-17 | 2003-07-31 | Smithkline Beecham Corporation | Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
| ATE485275T1 (de) | 2002-02-12 | 2010-11-15 | Glaxosmithkline Llc | Nicotinamide und deren verwendung als p38 inhibitoren |
| GB0217757D0 (en) | 2002-07-31 | 2002-09-11 | Glaxo Group Ltd | Novel compounds |
| DE60329316D1 (de) | 2002-11-12 | 2009-10-29 | Merck & Co Inc | Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer |
| GB0228410D0 (en) | 2002-12-05 | 2003-01-08 | Glaxo Group Ltd | Novel Compounds |
| GB0308186D0 (en) * | 2003-04-09 | 2003-05-14 | Smithkline Beecham Corp | Novel compounds |
| GB0308185D0 (en) * | 2003-04-09 | 2003-05-14 | Smithkline Beecham Corp | Novel compounds |
| GB0308201D0 (en) * | 2003-04-09 | 2003-05-14 | Smithkline Beecham Corp | Novel compounds |
| GB0318814D0 (en) * | 2003-08-11 | 2003-09-10 | Smithkline Beecham Corp | Novel compounds |
| CN103784458B (zh) * | 2003-12-22 | 2015-10-14 | 味之素株式会社 | 苯基丙氨酸衍生物 |
| GB0402143D0 (en) * | 2004-01-30 | 2004-03-03 | Smithkline Beecham Corp | Novel compounds |
| US20080051416A1 (en) * | 2004-10-05 | 2008-02-28 | Smithkline Beecham Corporation | Novel Compounds |
| GB0512429D0 (en) * | 2005-06-17 | 2005-07-27 | Smithkline Beecham Corp | Novel compound |
| MX2009007050A (es) | 2006-12-29 | 2009-09-23 | Abbott Gmbh & Co Kg | Compuestos de carboxamida y su uso como inhibidores de calpaina. |
| TWI453019B (zh) | 2007-12-28 | 2014-09-21 | Abbvie Deutschland | 甲醯胺化合物 |
| AR077525A1 (es) * | 2009-01-30 | 2011-09-07 | Novartis Ag | 4-aril-butan-1,3-diamidas y composiciones farmaceuticas |
| TWI519530B (zh) | 2009-02-20 | 2016-02-01 | 艾伯維德國有限及兩合公司 | 羰醯胺化合物及其作為鈣蛋白酶（ｃａｌｐａｉｎ）抑制劑之用途 |
| JP2015512427A (ja) | 2012-04-03 | 2015-04-27 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | カルボキサミド化合物およびそれのカルパイン阻害薬ｖとしての使用 |
| MX388871B (es) | 2014-06-27 | 2025-03-20 | Nogra Pharma Ltd | Moduladores del receptor arilo y metodos para elaborar y usar los mismos. |
| EP3426674A4 (en) | 2016-03-09 | 2019-08-14 | Blade Therapeutics, Inc. | CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF |
| WO2018009417A1 (en) | 2016-07-05 | 2018-01-11 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
| SG10201912574WA (en) | 2016-09-28 | 2020-02-27 | Blade Therapeutics Inc | Calpain modulators and therapeutic uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ305626A (en) | 1995-03-24 | 2000-01-28 | Axys Pharm Inc | Reversible protease inhibitors |
| EP0923535A4 (en) * | 1996-08-28 | 2001-01-10 | Smithkline Beecham Corp | CYSTEINE PROTEASE INHIBITORS |
| IL130124A0 (en) | 1996-12-11 | 2000-06-01 | Basf Ag | Ketobenzamides as calpain inhibitors |
-
1998
- 1998-04-20 DE DE19817461A patent/DE19817461A1/de not_active Withdrawn
-
1999
- 1999-04-19 CA CA002328430A patent/CA2328430A1/en not_active Abandoned
- 1999-04-19 ID IDW20002113A patent/ID26305A/id unknown
- 1999-04-19 AU AU38186/99A patent/AU743245B2/en not_active Ceased
- 1999-04-19 KR KR1020007011601A patent/KR20010042837A/ko not_active Withdrawn
- 1999-04-19 EP EP99920704A patent/EP1073632A1/de not_active Withdrawn
- 1999-04-19 BR BR9909776-1A patent/BR9909776A/pt not_active IP Right Cessation
- 1999-04-19 WO PCT/EP1999/002617 patent/WO1999054293A1/de not_active Application Discontinuation
- 1999-04-19 CN CN99807638A patent/CN1306509A/zh active Pending
- 1999-04-19 CZ CZ20003890A patent/CZ20003890A3/cs unknown
- 1999-04-19 JP JP2000544634A patent/JP2002512220A/ja active Pending
- 1999-04-19 SK SK1412-2000A patent/SK14122000A3/sk unknown
- 1999-04-19 PL PL99343466A patent/PL343466A1/xx not_active Application Discontinuation
- 1999-04-19 HR HR20000777A patent/HRP20000777A2/hr not_active Application Discontinuation
- 1999-04-19 IL IL13867699A patent/IL138676A0/xx unknown
- 1999-04-19 US US09/647,673 patent/US6436925B1/en not_active Expired - Fee Related
- 1999-04-19 TR TR2000/03069T patent/TR200003069T2/xx unknown
- 1999-04-19 HU HU0101616A patent/HUP0101616A3/hu unknown
-
2000
- 2000-10-13 BG BG104856A patent/BG104856A/xx unknown
- 2000-10-19 NO NO20005265A patent/NO20005265D0/no not_active Application Discontinuation
- 2000-11-20 ZA ZA200006758A patent/ZA200006758B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0101616A1 (hu) | 2001-09-28 |
| AU743245B2 (en) | 2002-01-24 |
| BG104856A (en) | 2001-05-31 |
| NO20005265L (no) | 2000-10-19 |
| NO20005265D0 (no) | 2000-10-19 |
| PL343466A1 (en) | 2001-08-13 |
| CA2328430A1 (en) | 1999-10-28 |
| KR20010042837A (ko) | 2001-05-25 |
| EP1073632A1 (de) | 2001-02-07 |
| CN1306509A (zh) | 2001-08-01 |
| US6436925B1 (en) | 2002-08-20 |
| DE19817461A1 (de) | 1999-10-21 |
| WO1999054293A1 (de) | 1999-10-28 |
| HUP0101616A3 (en) | 2002-10-28 |
| TR200003069T2 (tr) | 2009-01-21 |
| JP2002512220A (ja) | 2002-04-23 |
| AU3818699A (en) | 1999-11-08 |
| CZ20003890A3 (cs) | 2001-11-14 |
| IL138676A0 (en) | 2001-10-31 |
| SK14122000A3 (sk) | 2001-05-10 |
| HRP20000777A2 (en) | 2001-06-30 |
| ZA200006758B (en) | 2001-12-12 |
| BR9909776A (pt) | 2000-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID26305A (id) | Benzamida tersubstitusi baru, pembuatan dan penggunaannya | |
| ID27757A (id) | Indolinona-indolinona tersubstitusi baru, preparasi dan penggunaannya sebagai obat | |
| ID26420A (id) | Indolinon-indolinon tersubstitusi baru, pembuatannya dan penggunaannya sebagai komposisi-komposisi farmasi | |
| ID26402A (id) | Amida-amida tersubstitusi yang baru, pembuatan dan penggunaannya | |
| ID28787A (id) | 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya | |
| ID19824A (id) | Turunan-turunan ditiolan, pembuatannya dan pengaruh terapinya | |
| ID26728A (id) | Amida-amida baru dengan pensubstitusi heterosiklik, pembuatan dan penggunaannya | |
| ID26351A (id) | Isosianat-isosianat oligomerik tersumbat, pembuatan dan penggunaannya | |
| ID28846A (id) | 2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya | |
| ID27263A (id) | Dihidropirimidina baru | |
| ID18925A (id) | Penggunaan benzazol-benzazol yang disubstitusi sebagai absorben-absorben uv, benzazol-benzazol baru dan proses-proses untuk pembuatannya | |
| ID27558A (id) | Amida-amida aromatik baru, metode pembuatannya dan penggunaannya sebagai obat | |
| ID28997A (id) | Kedok sekali pakai, dan proses pembuatannya | |
| EE9700354A (et) | Trombiini uued inhibiitorid, nende saamine ja kasutamine | |
| ID28166A (id) | Formulasi partikulat baru | |
| ID25528A (id) | Karboksamidotiazol tersubstitusi, pembuatannya dan komposisi farmasi yang mengandungnya | |
| ID22490A (id) | Benzamida-benzamida yang disubstitusi secara heterosiklik yang baru dan penggunaannya | |
| ID21781A (id) | Benzamidoaldehida baru dan penggunaannya | |
| ID17686A (id) | Fotoinisiator alpha-aminoasetofenon baru | |
| ID27289A (id) | Penggunaan yang baru | |
| FI973427L (fi) | Uusia blokkikopolymeerejä ja niiden valmistus | |
| ID28286A (id) | Antibiotik-antibiotik makrolida baru | |
| ID24714A (id) | Turunan tiazolidindion tersubstitusi, proses pembuatannya dan penggunaan bahan farmasinya | |
| ID20855A (id) | Senyawa turunan imidazolidin baru, pembuatannya, penggunaannya dan sediaan farmasi yang mengandung senyawa tersebut | |
| ID21525A (id) | Komposisi bedak baru |